Recombinant Bos indicus NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

Shipped with Ice Packs
In Stock

Description

Recombinant Production Methods

Recombinant MT-ND4L is synthesized using heterologous expression systems to overcome challenges in isolating native mitochondrial proteins. Key production strategies include:

Expression Systems

  • Escherichia coli: Widely used for cost-effective, high-yield production (e.g., His-tagged constructs) .

  • Yeast: Offers eukaryotic post-translational modifications; purity >85% achieved via SDS-PAGE .

  • Baculovirus: Suitable for large-scale mammalian-like protein folding .

Role in Complex I Assembly

Studies in Chlamydomonas reinhardtii demonstrate that MT-ND4L is essential for assembling the 950-kDa Complex I structure. Knockdown of ND4L via RNA interference abolished enzyme activity, highlighting its non-redundant role .

Disease Associations

  • Leber’s Hereditary Optic Neuropathy (LHON): The T10,663C mutation in MT-ND4L disrupts electron transfer, leading to ATP synthesis defects and optic nerve degeneration .

  • Metabolic Disorders: Variants correlate with altered body mass index (BMI) and risks of obesity/diabetes, likely due to impaired oxidative phosphorylation .

Biotechnological Use

Recombinant MT-ND4L is utilized in:

  • ELISA Kits: Detects native MT-ND4L in biological samples (e.g., MBS7225312 kit) .

  • Functional Studies: Investigating proton-pumping mechanisms and drug interactions .

Challenges and Future Directions

  • Structural Resolution: MT-ND4L’s hydrophobicity complicates crystallization; cryo-EM studies are ongoing .

  • Species-Specific Variations: Further sequencing of Bos indicus mitochondria is needed to clarify unique functional motifs.

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have specific requirements for the format, please indicate them in your order notes. We will accommodate your request to the best of our ability.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please contact your local distributor for specific delivery timeframes.
Note: All proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial before opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers may use this as a reference point.
Shelf Life
Shelf life is influenced by various factors, including storage conditions, buffer composition, storage temperature, and the inherent stability of the protein.
Generally, liquid formulations have a shelf life of 6 months at -20°C/-80°C. Lyophilized formulations have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production. If you have a specific tag type preference, please inform us, and we will prioritize developing the specified tag.
Synonyms
MT-ND4L; MTND4L; NADH4L; ND4L; NADH-ubiquinone oxidoreductase chain 4L; NADH dehydrogenase subunit 4L
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-98
Protein Length
full length protein
Species
Bos indicus (Zebu)
Target Names
Target Protein Sequence
MSMVYMNIMMAFTVSLVGLLMYRSHLMSSLLCLEGMMLSLFVMAALTILNSHFTLASMMP IILLVFAACEAALGLSLLVMVSNTYGTDYVQNLNLLQC
Uniprot No.

Target Background

Function
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor.
Database Links

KEGG: biu:2885969

Protein Families
Complex I subunit 4L family
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What is MT-ND4L and what role does it play in mitochondrial function?

MT-ND4L (NADH-ubiquinone oxidoreductase chain 4L) is a highly hydrophobic subunit of mitochondrial complex I, the first enzyme in the electron transport chain of aerobically respiring organisms. As part of the NADH dehydrogenase complex (EC 1.6.5.3), MT-ND4L contributes to the oxidation of NADH and the reduction of ubiquinone, coupled to proton translocation across the inner mitochondrial membrane. This process is fundamental to cellular energy production via oxidative phosphorylation . The protein is encoded by the mitochondrial genome rather than nuclear DNA, which has significant implications for inheritance patterns, mutation rates, and evolutionary conservation. In complex I, which consists of more than 40 subunits in mammals, MT-ND4L works alongside other mitochondrially-encoded subunits (ND1, -2, -3, -4, -5, and -6) to form the membrane domain responsible for proton pumping .

How conserved is MT-ND4L across different Bos species and what are the implications for research?

MT-ND4L shows notable conservation across Bos species, reflecting its essential role in cellular respiration. While the search results focus primarily on Bos mutus grunniens (wild yak) , comparative genomic analyses have demonstrated high sequence similarity between bovine species such as Bos taurus (domestic cattle), Bos indicus (zebu), and Bos mutus grunniens.

The high conservation of MT-ND4L has important implications for researchers:

  • Findings from one Bos species can often be extrapolated to others with appropriate validation

  • Functional regions of the protein are typically under stronger evolutionary constraint

  • Species-specific variations may highlight regions less critical for core protein function or adaptations to different environmental conditions

  • Recombinant proteins from different species can potentially substitute for each other in certain experimental contexts

Researchers should carefully document the specific species origin of their MT-ND4L protein and consider species-specific variations when interpreting experimental results, particularly when studying subtle functional aspects or when developing species-specific antibodies or other detection tools .

What are the optimal storage and handling conditions for recombinant MT-ND4L to maintain functionality?

Recombinant MT-ND4L requires specific storage and handling protocols to maintain its structural integrity and functionality due to its hydrophobic nature. Based on established protocols for similar proteins, the following recommendations apply:

Storage Conditions:

  • Store at -20°C for routine use; for extended storage, conserve at -80°C

  • Store in a Tris-based buffer containing 50% glycerol optimized for protein stability

  • Avoid repeated freeze-thaw cycles as they significantly reduce protein activity

  • For working aliquots, store at 4°C for no more than one week

Handling Considerations:

  • Due to the protein's hydrophobicity, addition of mild detergents (such as dodecylmaltoside at 0.1-0.5%) may be necessary to maintain solubility during experimental procedures

  • When conducting assays, protein concentration should be determined using the Bradford method to account for the presence of detergents

  • For incorporation into liposomes or nanodiscs to study membrane protein function, specialized protocols for hydrophobic protein reconstitution should be employed

These precautions are essential to obtain reliable and reproducible results in experimental studies involving MT-ND4L, as improper storage or handling can lead to protein aggregation, denaturation, and loss of functional activity.

What expression systems are most effective for producing functional recombinant MT-ND4L for research purposes?

Producing functional recombinant MT-ND4L presents significant challenges due to its hydrophobic nature and mitochondrial origin. Based on research with similar membrane proteins, the following expression systems have proven effective, each with distinct advantages:

Bacterial Expression Systems:

  • E. coli with specialized strains (C41, C43, or Rosetta strains) designed for membrane protein expression

  • Fusion with solubility-enhancing tags (MBP, SUMO, or thioredoxin) may improve yield

  • Codon optimization for bacterial expression is critical due to differences in mitochondrial and bacterial genetic codes

Eukaryotic Expression Systems:

  • Insect cell systems (Sf9, Sf21, or High Five cells) with baculovirus vectors often yield properly folded complex I subunits

  • Mammalian expression systems (HEK293, CHO cells) provide native post-translational modifications and assembly partners

  • Yeast systems (Pichia pastoris) combine ease of culture with eukaryotic processing capabilities

Cell-Free Expression Systems:

  • Wheat germ or rabbit reticulocyte lysate systems with added detergents or lipids can produce functional membrane proteins

  • These systems avoid toxicity issues that may occur during in vivo expression

The choice of expression system should be guided by the intended experimental application. For structural studies requiring large protein quantities, bacterial or insect cell systems may be preferable. For functional studies examining interactions with other complex I components, mammalian expression systems might provide more native-like protein .

What techniques are most effective for studying the interaction between MT-ND4L and other complex I subunits?

Investigating the interactions between MT-ND4L and other complex I subunits requires specialized techniques that can capture both stable and transient associations within the membrane environment. The following methodologies have proven valuable:

Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE):

  • Allows visualization of intact protein complexes

  • Can be combined with second-dimension SDS-PAGE to identify individual subunits

  • Protein complexes should be solubilized with appropriate detergents (typically 2.5% dodecylmaltoside in 375 mM 6-aminohexanoic acid, 250 mM EDTA, and 25 mM Bis-Tris, pH 7.0)

Crosslinking Mass Spectrometry:

  • Uses chemical crosslinkers to capture protein-protein interactions

  • MS/MS analysis identifies crosslinked peptides, revealing proximity relationships

  • Zero-length crosslinkers or variable-length crosslinkers can provide detailed spatial information

Cryo-Electron Microscopy:

  • Provides structural information about the entire complex

  • Can reveal the position and orientation of MT-ND4L within complex I

  • Particularly valuable for membrane protein complexes that resist crystallization

Co-immunoprecipitation and Pull-down Assays:

  • Requires antibodies against MT-ND4L or epitope tags

  • Can identify stable interaction partners

  • May need to be performed in the presence of appropriate detergents

Computational Structural Genomics:

  • Molecular dynamics simulations can predict interactions between subunits

  • Can model effects of mutations on subunit interactions

  • Enables analysis of allosteric communication pathways between subunits

Each of these techniques provides complementary information. For comprehensive understanding of MT-ND4L interactions, researchers should employ multiple approaches and validate findings across different experimental systems .

How do mutations in MT-ND4L affect complex I function and what methodologies best detect these effects?

Mutations in MT-ND4L can significantly disrupt complex I function through various mechanisms, affecting energy production and cellular homeostasis. The impact of these mutations can be assessed through several complementary approaches:

Enzymatic Activity Assays:

  • NADH:ubiquinone oxidoreductase activity measurements using spectrophotometric methods

  • Comparison of rotenone-sensitive vs. insensitive activity to distinguish between physiological and non-physiological electron transfer pathways

  • Measurement of NADH:ferricyanide oxidoreductase activity to assess the integrity of the NADH binding site

Structural Stability Analysis:

  • Molecular mechanics calculations of folding energy to identify stabilizing or destabilizing effects

  • Temperature sensitivity assays to detect decreased structural stability

  • Protease susceptibility assays to identify conformational changes

Electron Transfer Kinetics:

  • Stopped-flow kinetic measurements to detect changes in electron transfer rates

  • Analysis of semiquinone formation and stability using EPR spectroscopy

  • Measurement of proton pumping efficiency using pH-sensitive probes or reconstituted systems

Computational Approaches:

  • Allosteric pathway analysis to identify communication disruptions between subunits

  • Evolutionary coupling analysis to detect the functional importance of residue positions

  • Molecular dynamics simulations to predict effects on protein motion and flexibility

Case study evidence from the analysis of the MT-ND4L:G86D mutation demonstrates how these approaches can be integrated. This mutation was found to be potentially pathogenic in myelodysplastic syndromes and was confirmed deleterious through:

  • Evolutionary coupling analysis identifying it as functionally critical

  • Allosteric path analysis showing disruption of communication pathways

  • Structural stability analysis revealing highly destabilizing effects

These findings demonstrate that comprehensive mutational analysis requires integration of biochemical, biophysical, and computational approaches to fully understand the molecular consequences of MT-ND4L variants.

What is the relationship between MT-ND4L mutations and mitochondrial disease phenotypes?

Mutations in MT-ND4L contribute to a spectrum of mitochondrial diseases through disruption of complex I assembly and function. The relationship between specific mutations and disease phenotypes is complex, influenced by heteroplasmy (the proportion of mutated to wild-type mitochondrial DNA), tissue-specific expression patterns, and interactions with nuclear genes.

Disease Associations:

  • Myelodysplastic syndromes (MDS): MT-ND4L mutations have been identified as prognostic indicators for outcomes following allogeneic hematopoietic stem-cell transplantation (allo-HCT)

  • Leber's hereditary optic neuropathy (LHON)-like syndromes

  • Leigh syndrome and Leigh-like phenotypes

  • Mitochondrial encephalomyopathy presentations

Mutation-Phenotype Correlations:

  • The MT-ND4L:G86D mutation has been associated with poor outcomes in MDS patients receiving allo-HCT

  • This mutation is considered deleterious based on computational structural genomics analysis, affecting complex I stability and function

Biochemical Consequences:

  • Reduced complex I assembly and stability

  • Decreased NADH:ubiquinone oxidoreductase activity

  • Increased production of reactive oxygen species

  • Altered mitochondrial membrane potential

  • Compromised ATP production

Tissue-Specific Effects:
The differential impact of MT-ND4L mutations across tissues likely reflects:

  • Varying energy demands between tissues

  • Tissue-specific mitochondrial dynamics

  • Compensatory mechanisms that may be more effective in certain cell types

  • Interaction with tissue-specific nuclear-encoded factors

Research approaches to understand these relationships include patient cohort studies, functional validation in cellular models, creation of cybrid cell lines containing patient-derived mitochondria, and the use of computational structural genomics to predict the impact of specific variants . These integrated approaches are essential for establishing reliable genotype-phenotype correlations and developing targeted therapeutic strategies.

What computational methods are most effective for predicting the structural impacts of MT-ND4L variants?

Advanced computational methods have transformed our ability to predict how mutations in MT-ND4L affect its structure and function. A systematic approach integrating multiple computational techniques provides the most reliable predictions:

Molecular Mechanics Calculations:

  • Calculate folding energy changes (ΔΔG) upon mutation to assess structural stability

  • Identify whether mutations are stabilizing, neutral, or destabilizing

  • Example finding: The MT-ND4L:G86D mutation is highly destabilizing to the protein structure

Molecular Dynamics Simulations:

  • Perform accelerated molecular dynamics to sample conformational space efficiently

  • Analyze changes in protein flexibility, internal cavities, and interaction networks

  • Identify altered motion patterns that may affect electron transport or proton pumping

Evolutionary Coupling Analysis (ECA):

  • Identify co-evolving residue pairs that are functionally or structurally coupled

  • Predict the functional importance of specific residues based on evolutionary conservation

  • In a study of seven complex I variants, ECA successfully identified all as deleterious

Allosteric Pathway Analysis:

  • Map communication networks within the protein structure

  • Identify residues critical for transmitting conformational changes

  • Successfully identified six out of seven complex I variants as deleterious in a recent study

Structure-Based Prediction Workflow:

  • Build homology model if experimental structure is unavailable

  • Introduce mutation in silico

  • Perform energy minimization

  • Run molecular dynamics simulations (100-500 ns)

  • Analyze trajectory for structural changes

  • Calculate energetics and stability changes

  • Identify altered interaction networks

  • Map changes to functional domains

These computational approaches have demonstrated superior performance compared to traditional sequence-based methods. In a study of mitochondrial variants associated with myelodysplastic syndromes, computational structural genomics outperformed conventional analytical methods in predicting pathogenicity and provided mechanistic explanations for the observed effects .

How does the structure of MT-ND4L contribute to the electron transport mechanism of complex I?

Structural Position and Interactions:

  • MT-ND4L is embedded in the membrane domain of complex I

  • It interacts directly with other membrane-bound subunits, particularly MT-ND4 and MT-ND5

  • These interactions stabilize the complex and maintain the architecture necessary for proton pumping

Contribution to Electron Transport Pathway:

  • While not directly involved in the initial electron acceptance from NADH (which occurs at the flavin site)

  • MT-ND4L helps maintain the structural integrity of the ubiquinone binding site

  • Its transmembrane helices contribute to forming the proton translocation channel

  • The precise arrangement of charged and polar residues within MT-ND4L facilitates proton movement across the membrane

Mechanistic Role in Energy Transduction:

  • Electron transport from iron-sulfur clusters to ubiquinone generates conformational changes

  • These changes are propagated through MT-ND4L and other membrane subunits

  • The resulting conformational energy drives proton pumping across the membrane

  • MT-ND4L's strategic location couples electron transfer to proton translocation

Critical Residues and Domains:

  • Charged residues like glutamate (E) are particularly important

  • For instance, the E145 residue in the related MT-ND5 is located at the interface with MT-ND4

  • Such residues create a balance between architectural stability and essential flexibility

  • Mutations that alter charge distribution (e.g., E to K) or create internal cavities (e.g., E to G) can disrupt electron transport and proton pumping

This understanding of MT-ND4L's structural role comes from integrated studies combining cryo-electron microscopy, molecular dynamics simulations, and functional assays of complex I. As resolution of structural data improves, our understanding of MT-ND4L's precise role in electron transport continues to evolve .

What techniques can distinguish between physiological and non-physiological ubiquinone reduction pathways in complex I?

Complex I exhibits multiple ubiquinone reduction pathways that must be carefully distinguished in experimental settings. Identifying which pathway is active is crucial for interpreting research findings:

Inhibitor-Based Discrimination:

  • The physiological, energy-transducing pathway is sensitive to specific inhibitors

  • Rotenone and piericidin A selectively block the energy-transducing site (90-95% inhibition)

  • The non-energy-transducing pathway (at the flavin site) is relatively insensitive to these inhibitors

  • Experimental protocol: Compare activity with and without inhibitors (10 μM rotenone or piericidin A)

Substrate Specificity Analysis:
Different ubiquinone analogs show preferential reactivity at the two sites:

Ubiquinone AnalogEnergy-Transducing SiteFlavin SiteInhibitor Sensitivity
Decylubiquinone (DQ)✓✓✓~95%
Ubiquinone-1 (Q₁)✓✓✓✓✓~90%
Ubiquinone-0 (Q₀)✓✓✓~50%
Idebenone (IDE)✓✓~60%

Note: The number of checkmarks indicates relative reactivity at each site

Phospholipid Dependence:

  • The energy-transducing pathway shows strong dependence on phospholipids

  • Adding phospholipids (e.g., asolectin at 0.4 mg/ml) significantly increases activity at the physiological site

  • The flavin site activity is less affected by phospholipid addition

  • This creates another parameter for distinguishing between pathways

Kinetic Analysis:

  • The flavin site exhibits a ping-pong reaction mechanism

  • The energy-transducing site follows a different kinetic pattern

  • Lineweaver-Burk plots with varying NADH and ubiquinone concentrations can differentiate these mechanisms

Reactive Oxygen Species (ROS) Production:

  • Reactions at the flavin site often generate superoxide and hydrogen peroxide

  • Monitor ROS production using fluorescent probes or chemiluminescence

  • High ROS production suggests flavin site activity

  • The physiological pathway produces minimal ROS

These complementary approaches provide researchers with a toolkit to reliably distinguish between the physiological and non-physiological pathways of ubiquinone reduction in complex I, ensuring accurate interpretation of experimental results involving MT-ND4L and other complex I components.

How can Bos indicus MT-ND4L serve as a model for human mitochondrial disease research?

Bos indicus MT-ND4L represents a valuable model system for investigating human mitochondrial diseases due to several advantageous features:

Structural and Functional Conservation:

  • The core structure and function of complex I are highly conserved between bovine and human mitochondria

  • Key functional residues in MT-ND4L show strong conservation across mammalian species

  • This conservation enables insights from bovine studies to inform human disease mechanisms

Experimental Advantages:

  • Bovine mitochondria can be isolated in large quantities from readily available tissue sources

  • Bovine complex I is stable and amenable to various biochemical and biophysical techniques

  • The respiratory chain components from bovine mitochondria have been extensively characterized

Disease-Relevant Mutations:

  • Many pathogenic mutations identified in human MT-ND4L affect residues that are conserved in Bos indicus

  • The MT-ND4L:G86D mutation studied in myelodysplastic syndromes corresponds to a conserved glycine residue across species

  • Computational structural genomics approaches validated on bovine models can be applied to predict pathogenicity of human variants

Translational Research Framework:

  • Identify human disease-associated MT-ND4L mutations

  • Introduce equivalent mutations into bovine MT-ND4L using recombinant expression systems

  • Characterize biochemical and structural consequences

  • Develop screening assays for therapeutic compounds

  • Validate findings in human cell models

This approach has been particularly valuable for understanding mtDNA mutations associated with myelodysplastic syndromes and their impact on patient outcomes following stem cell transplantation. The mechanisms elucidated using bovine models can guide development of personalized treatment approaches based on a patient's specific mitochondrial genotype .

What are the key challenges in studying MT-ND4L interactions with nuclear-encoded complex I subunits?

Investigating interactions between mitochondrially-encoded MT-ND4L and nuclear-encoded complex I subunits presents several significant challenges that researchers must address:

Coordinate Expression Systems:

  • MT-ND4L is translated on mitochondrial ribosomes using a modified genetic code

  • Nuclear-encoded subunits are synthesized on cytoplasmic ribosomes and imported into mitochondria

  • Reconstituting these processes in vitro requires sophisticated experimental systems

  • Possible solution: Use of cell-free coupled transcription-translation systems with purified mitochondrial and cytoplasmic ribosomes

Assembly Pathway Complexity:

  • Complex I assembly involves multiple intermediate complexes and assembly factors

  • MT-ND4L integrates into assembly intermediates at specific stages

  • Temporal coordination of subunit integration is difficult to replicate experimentally

  • Approach: Use of inducible expression systems to control timing of subunit expression

Hydrophobicity Barriers:

  • Both MT-ND4L and many nuclear-encoded membrane subunits are highly hydrophobic

  • Maintaining solubility while preserving native interactions is technically challenging

  • Strategy: Carefully optimized detergent conditions (e.g., dodecylmaltoside at 2.5%) or nanodisc/liposome reconstitution

Post-translational Modifications:

  • Both mitochondrial and nuclear-encoded subunits undergo post-translational modifications

  • These modifications can be critical for protein-protein interactions

  • Recombinant systems often lack the enzymes required for these modifications

  • Solution: Use of eukaryotic expression systems or enzyme-supplemented in vitro systems

Technical Approaches to Address These Challenges:

ChallengeTechnical ApproachAdvantagesLimitations
Coordinate expressionSplit-inteins for post-translational protein fusionAllows separate expression and subsequent joiningRequires intein tags that may interfere with function
HydrophobicityAmphipol stabilizationMaintains native structure in aqueous solutionMay mask interaction surfaces
Assembly orderPulse-chase with differentially tagged subunitsTracks assembly kineticsComplex experimental setup
Post-translational modificationsSite-specific incorporation of modified amino acidsPrecise control of modification stateLimited to certain modification types

Addressing these challenges requires complementary approaches combining in vitro reconstitution, cellular studies, and in silico modeling to fully understand the complex interactions between MT-ND4L and nuclear-encoded complex I components .

How can advanced computational approaches improve our understanding of MT-ND4L's role in mitochondrial disease?

Computational approaches are revolutionizing our understanding of MT-ND4L's role in mitochondrial diseases, offering insights that were previously unattainable through experimental methods alone:

Comprehensive Variant Phenotyping:

  • Computational structural genomics enables deep phenotyping of MT-ND4L variants

  • This approach integrates structural modeling, molecular mechanics calculations, and molecular dynamics simulations

  • It allows prediction of variant effects on protein structure and function at the atomic level

  • Such analyses have successfully characterized variants in complex I genes (including MT-ND4L) associated with myelodysplastic syndromes

Mechanisms of Dysfunction:
Computational methods can reveal specific mechanisms of protein dysfunction:

  • Identification of mutant-specific cavities that alter protein dynamics

  • Changes in electrostatic interactions that affect proton transfer

  • Disruptions in allosteric communication pathways between subunits

  • Alterations in protein flexibility that impact complex assembly or stability

For example, computational analysis revealed that the MT-ND4L:G86D mutation likely disrupts protein dynamics by introducing a negatively charged residue into a critical position .

Precision Medicine Applications:

  • Computational predictions can stratify variants based on predicted pathogenicity

  • This enables more accurate prognostic assessments for patients with mitochondrial diseases

  • In a study of MDS patients receiving allogeneic hematopoietic stem-cell transplantation, computational structural genomics improved prediction of patient outcomes compared to conventional methods

Drug Discovery Potential:

  • Conformations identified through molecular dynamics simulations can reveal mutant-specific binding pockets

  • These pockets can be targeted for the development of small molecule drugs

  • Virtual screening against these pockets can identify candidate compounds for experimental testing

  • This approach could lead to personalized treatments for specific MT-ND4L mutations

Integration with Experimental Data:
For maximum impact, computational approaches should be integrated with experimental validation:

  • Predictions from computational modeling guide targeted experimental designs

  • Experimental results refine computational models in an iterative process

  • Machine learning algorithms can identify patterns across multiple variants

  • Systems biology approaches connect MT-ND4L dysfunction to broader cellular processes

This integrative approach represents the frontier of mitochondrial disease research, promising improved diagnostic accuracy and targeted therapeutic strategies for disorders involving MT-ND4L mutations .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.